https://dermfield.com/articles/stage-iv-melanoma-at-50-nine-months-to-live-six-years Derm Field en 2026-11-10T00:44:28.664Z Stage IV Melanoma at 50: Nine Months to Live, Six Years On https://dermfield.com/articles/radiation-dermatitis-timeline-grades-and-skin-care Derm Field en 2026-11-10T00:44:28.664Z Radiation Dermatitis: Timeline, Grades, and Skin Care https://dermfield.com/articles/oral-psoriasis-therapies-54-pasi-100-and-dosing-differences Derm Field en 2026-11-10T00:24:26.375Z Oral psoriasis therapies: 54% PASI 100 and dosing differences https://dermfield.com/articles/patient-says-he-offered-thousands-out-of-pocket-for-a-psoriasis-biologic Derm Field en 2026-11-09T15:54:24.326Z Patient Says He Offered Thousands Out of Pocket for a Psoriasis Biologic https://dermfield.com/articles/estee-lauder-companies-unveils-skin-longevity-platform Derm Field en 2026-11-09T15:29:25.064Z Estée Lauder Companies unveils skin longevity platform https://dermfield.com/articles/medicube-lands-in-1-300-shoppers-drug-mart-stores-across-canada Derm Field en 2026-11-09T11:09:26.444Z Medicube Lands in 1,300 Shoppers Drug Mart Stores Across Canada https://dermfield.com/articles/boots-launches-seven-line-k-wellness-range-in-the-uk Derm Field en 2026-11-09T11:09:26.444Z Boots launches seven-line K-Wellness range in the UK https://dermfield.com/articles/personalized-mrna-vaccine-cuts-melanoma-recurrence-risk-42-in-phase-3 Derm Field en 2026-11-09T10:34:24.157Z Personalized mRNA Vaccine Cuts Melanoma Recurrence Risk 42% in Phase 3 https://dermfield.com/articles/dr-singhs-review-favors-decisiondx-in-melanoma-gep-testing Derm Field en 2026-11-09T00:29:23.268Z Dr. Singh’s Review Favors DecisionDx in Melanoma GEP Testing https://dermfield.com/articles/scars-never-vanish-why-skin-repairs-itself-with-inferior-collagen Derm Field en 2026-11-08T22:39:22.739Z Scars never vanish: why skin repairs itself with inferior collagen https://dermfield.com/articles/gpr35-links-linoleic-acid-breakdown-to-psoriasis-like-itch Derm Field en 2026-11-08T21:14:24.699Z Gpr35 Links Linoleic Acid Breakdown to Psoriasis-Like Itch https://dermfield.com/articles/plant-compound-brachycerine-blocked-uv-nerve-damage-in-human-skin-samples Derm Field en 2026-11-08T21:09:30.978Z Plant Compound Brachycerine Blocked UV Nerve Damage in Human Skin Samples https://dermfield.com/articles/pediatric-steroid-withdrawal-is-rare-counseling-is-key Derm Field en 2026-11-08T20:09:13.950Z Pediatric Steroid Withdrawal Is Rare; Counseling Is Key https://dermfield.com/articles/atto-1310-yields-82-pp-nrs4-itch-response-at-week-12 Derm Field en 2026-11-08T20:09:13.950Z ATTO-1310 Yields 82% PP-NRS4 Itch Response at Week 12 https://dermfield.com/articles/dermatology-practice-brief-access-training-and-whole-patient-care Derm Field en 2026-11-08T20:09:13.950Z Dermatology Practice Brief: Access, Training and Whole-Patient Care https://dermfield.com/articles/ra-lupus-systemic-sclerosis-linked-to-higher-squamous-cell-carcinoma-risk Derm Field en 2026-11-08T20:09:13.950Z RA, Lupus, Systemic Sclerosis Linked to Higher Squamous Cell Carcinoma Risk https://dermfield.com/articles/rare-registry-data-sharpen-acral-and-mucosal-melanoma-care Derm Field en 2026-11-08T20:09:13.950Z RARE Registry data sharpen acral and mucosal melanoma care https://dermfield.com/articles/evx-01-melanoma-trial-reports-75-response-rate-and-t-cell-activity Derm Field en 2026-11-08T20:09:13.950Z EVX-01 melanoma trial reports 75% response rate and T-cell activity https://dermfield.com/articles/vet3-tgi-yields-71-response-rate-in-refractory-cutaneous-malignancies Derm Field en 2026-11-08T20:09:13.950Z VET3-TGI yields 71% response rate in refractory cutaneous malignancies https://dermfield.com/articles/rp1nivolumab-preserves-quality-adjusted-survival-in-melanoma Derm Field en 2026-11-08T20:09:13.950Z RP1–nivolumab preserves quality-adjusted survival in melanoma https://dermfield.com/articles/one-in-four-women-with-psoriasis-reported-delaying-motherhood Derm Field en 2026-11-08T20:09:13.950Z One in four women with psoriasis reported delaying motherhood https://dermfield.com/articles/vet3-tgi-shows-71-response-rate-in-cutaneous-malignancies Derm Field en 2026-11-08T20:09:13.950Z VET3-TGI shows 71% response rate in cutaneous malignancies https://dermfield.com/articles/alopecia-areata-case-highlights-facial-loss-and-jak-screening Derm Field en 2026-11-08T20:09:13.950Z Alopecia Areata Case Highlights Facial Loss and JAK Screening https://dermfield.com/articles/why-hedgehog-inhibitors-are-not-interchangeable-in-advanced-bcc Derm Field en 2026-11-08T20:09:13.950Z Why Hedgehog Inhibitors Are Not Interchangeable in Advanced BCC https://dermfield.com/articles/dermatologists-face-estimated-6-medicare-payment-cut Derm Field en 2026-11-08T20:09:13.950Z Dermatologists Face Estimated 6% Medicare Payment Cut in 2027 https://dermfield.com/articles/hidradenitis-suppurativa-7-year-diagnostic-gap-early-treatment Derm Field en 2026-11-08T20:09:13.950Z Hidradenitis suppurativa: 7-year diagnostic gap, early treatment https://dermfield.com/articles/average-370-mile-travel-highlights-rare-melanoma-trial-barriers Derm Field en 2026-11-08T20:09:13.950Z Average 370-Mile Travel Highlights Rare Melanoma Trial Barriers https://dermfield.com/articles/after-30-years-comorbidity-and-cost-redirected-psoriasis-care Derm Field en 2026-11-08T20:09:13.950Z After 30 Years, Comorbidity and Cost Redirected Psoriasis Care https://dermfield.com/articles/alopecia-areata-cases-define-a-path-to-systemic-care Derm Field en 2026-11-08T20:09:13.950Z Alopecia Areata Cases Define a Path to Systemic Care https://dermfield.com/articles/dupilumab-and-growth-trends-in-pediatric-atopic-dermatitis Derm Field en 2026-11-08T20:09:13.950Z Dupilumab and Growth Trends in Pediatric Atopic Dermatitis https://dermfield.com/articles/vitamin-b12-shots-energy-fix-or-costly-placebo-effect Derm Field en 2026-11-08T20:09:13.950Z Vitamin B12 shots: Energy fix or costly placebo effect? https://dermfield.com/articles/systemic-therapy-selection-in-pediatric-and-adult-atopic-dermatitis Derm Field en 2026-11-08T20:09:13.950Z Systemic Therapy Selection in Pediatric and Adult Atopic Dermatitis https://dermfield.com/articles/tildrakizumab-every-12-weeks-fits-shift-workers-panel-weighs-scalp-and-nail-data Derm Field en 2026-11-08T20:09:13.950Z Tildrakizumab Every 12 Weeks Fits Shift Workers; Panel Weighs Scalp and Nail Data https://dermfield.com/articles/461-000-licensed-nps-and-counting-what-np-week-signals-for-practices Derm Field en 2026-11-08T20:04:16.787Z 461,000 Licensed NPs and Counting: What NP Week 2026 Signals for Practices https://dermfield.com/articles/neoadjuvant-cemiplimab-hit-36-pcr-in-high-risk-cscc-trial Derm Field en 2026-11-08T20:04:16.787Z Neoadjuvant Cemiplimab Hit 36% pCR in High-Risk CSCC Trial https://dermfield.com/articles/microtox-monopolar-rf-and-315-cc-caps-inside-the-undetectable-aesthetics-shift Derm Field en 2026-11-08T20:04:16.787Z Microtox, Monopolar RF and 315-cc Caps: Inside the Undetectable Aesthetics Shift https://dermfield.com/articles/global-cosmetics-regulation-roundup-eu-burden-tariffs-saudi-ban Derm Field en 2026-11-08T20:04:16.787Z Global Cosmetics Regulation Roundup: EU Burden, Tariffs, 2027 Saudi Ban https://dermfield.com/articles/intratumoral-il-12-mrna-shrinks-distant-lesions-in-pd-1resistant-melanoma Derm Field en 2026-11-08T20:04:16.787Z Intratumoral IL-12 mRNA Shrinks Distant Lesions in PD-1–Resistant Melanoma